CA1059411A - Competitive binding thyroid assay with improved bound-free separation step - Google Patents
Competitive binding thyroid assay with improved bound-free separation stepInfo
- Publication number
- CA1059411A CA1059411A CA269,836A CA269836A CA1059411A CA 1059411 A CA1059411 A CA 1059411A CA 269836 A CA269836 A CA 269836A CA 1059411 A CA1059411 A CA 1059411A
- Authority
- CA
- Canada
- Prior art keywords
- resin
- thyroid hormone
- thyroid
- competitive binding
- accordance
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 230000009137 competitive binding Effects 0.000 title claims abstract description 16
- 210000001685 thyroid gland Anatomy 0.000 title claims abstract description 11
- 238000000926 separation method Methods 0.000 title abstract description 12
- 238000003556 assay Methods 0.000 title abstract description 7
- 239000011347 resin Substances 0.000 claims abstract description 48
- 229920005989 resin Polymers 0.000 claims abstract description 48
- 239000003957 anion exchange resin Substances 0.000 claims abstract description 24
- AUYYCJSJGJYCDS-LBPRGKRZSA-N Thyrolar Chemical class IC1=CC(C[C@H](N)C(O)=O)=CC(I)=C1OC1=CC=C(O)C(I)=C1 AUYYCJSJGJYCDS-LBPRGKRZSA-N 0.000 claims abstract description 23
- 239000005495 thyroid hormone Substances 0.000 claims abstract description 23
- 229940036555 thyroid hormone Drugs 0.000 claims abstract description 23
- 108091008324 binding proteins Proteins 0.000 claims abstract description 5
- 125000001931 aliphatic group Chemical group 0.000 claims abstract description 4
- 210000002966 serum Anatomy 0.000 claims description 24
- 239000000243 solution Substances 0.000 claims description 13
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 5
- 238000012875 competitive assay Methods 0.000 claims description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 5
- 239000012085 test solution Substances 0.000 claims description 5
- 102000023732 binding proteins Human genes 0.000 claims description 4
- 239000001913 cellulose Substances 0.000 claims description 4
- 235000010980 cellulose Nutrition 0.000 claims description 4
- 229920002678 cellulose Polymers 0.000 claims description 4
- 108091023025 thyroid hormone binding Proteins 0.000 claims description 4
- 102000028501 thyroid hormone-binding Human genes 0.000 claims description 4
- 150000001412 amines Chemical group 0.000 claims description 2
- 239000000700 radioactive tracer Substances 0.000 claims 3
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 claims 2
- 239000003456 ion exchange resin Substances 0.000 claims 2
- 229920003303 ion-exchange polymer Polymers 0.000 claims 2
- 102000014914 Carrier Proteins Human genes 0.000 abstract 1
- 125000003277 amino group Chemical group 0.000 abstract 1
- 238000000034 method Methods 0.000 description 25
- 239000006228 supernatant Substances 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000003795 chemical substances by application Substances 0.000 description 5
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 238000005349 anion exchange Methods 0.000 description 3
- 125000003118 aryl group Chemical group 0.000 description 3
- 235000019365 chlortetracycline Nutrition 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- 150000001450 anions Chemical class 0.000 description 2
- 230000027455 binding Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 102000004506 Blood Proteins Human genes 0.000 description 1
- 108010017384 Blood Proteins Proteins 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000004067 bulking agent Substances 0.000 description 1
- 239000013043 chemical agent Substances 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 238000003795 desorption Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 125000000524 functional group Chemical group 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000003359 percent control normalization Methods 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 229920001467 poly(styrenesulfonates) Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000003127 radioimmunoassay Methods 0.000 description 1
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000007916 tablet composition Substances 0.000 description 1
- 238000012422 test repetition Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
- G01N33/78—Thyroid gland hormones, e.g. T3, T4, TBH, TBG or their receptors
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/804—Radioisotope, e.g. radioimmunoassay
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/825—Pretreatment for removal of interfering factors from sample
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S436/00—Chemistry: analytical and immunological testing
- Y10S436/826—Additives, e.g. buffers, diluents, preservatives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US05/685,595 US4015939A (en) | 1976-05-12 | 1976-05-12 | Competitive binding thyroid assay with improved bound-free separation step |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA1059411A true CA1059411A (en) | 1979-07-31 |
Family
ID=24752889
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA269,836A Expired CA1059411A (en) | 1976-05-12 | 1977-01-17 | Competitive binding thyroid assay with improved bound-free separation step |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US4015939A (https=) |
| JP (1) | JPS52138996A (https=) |
| CA (1) | CA1059411A (https=) |
| DE (1) | DE2701462A1 (https=) |
| GB (1) | GB1557267A (https=) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4115537A (en) * | 1976-09-07 | 1978-09-19 | American Hospital Supply Corporation | Resin tablet and use thereof in diagnostic tests |
| IT1206354B (it) * | 1977-03-10 | 1989-04-21 | Lepetit Spa | Corredo da usarsi per la determinazione degli ormoni liberi nei fluidi biologici |
| US4211763A (en) * | 1977-08-08 | 1980-07-08 | The Dow Chemical Company | Anion exchange resin in the determination of thyroid function |
| US4135880A (en) * | 1977-08-19 | 1979-01-23 | Bio-Rad Laboratories, Inc. | Folate assay with ion exchange resin bound-free separation |
| DE3044385A1 (de) * | 1980-11-25 | 1982-06-24 | Boehringer Mannheim Gmbh, 6800 Mannheim | Verfahren zur durchfuehrung analytischer bestimmungen und hierfuer geeignetes rotoreinsatzelement |
| US4442218A (en) * | 1981-05-27 | 1984-04-10 | Corning Glass Works | Method of measuring degree of partitioning |
| US5198340A (en) * | 1991-01-17 | 1993-03-30 | Genentech, Inc. | Assay for free igf-i, igf-ii, and gh levels in body fluids |
| US20030224047A1 (en) * | 2001-02-15 | 2003-12-04 | Franz G. Andrew | Levothyroxine compositions and methods |
| US6555581B1 (en) | 2001-02-15 | 2003-04-29 | Jones Pharma, Inc. | Levothyroxine compositions and methods |
| US20030032675A1 (en) * | 2001-02-15 | 2003-02-13 | Franz G. Andrew | Manufacture of thyroid hormone tablets having consistent active moiety amounts |
| US7067148B2 (en) * | 2001-02-15 | 2006-06-27 | King Pharmaceutical Research & Development, Inc. | Stabilized pharmaceutical and thyroid hormone compositions and method of preparation |
| US20030180353A1 (en) * | 2001-08-10 | 2003-09-25 | Franz G. Andrew | Stabilized pharmaceutical compositions |
| US20030190349A1 (en) * | 2001-08-10 | 2003-10-09 | Franz G. Andrew | Methods of stabilizing pharmaceutical compositions |
| US20030198667A1 (en) * | 2001-08-10 | 2003-10-23 | Franz Andrew G. | Methods of producing dispersible pharmaceutical compositions |
| US20030198671A1 (en) * | 2001-08-10 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique plasma AUC properties |
| US20030198672A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique triidothyronine plasma AUC properties |
| US20030199586A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Unique levothyroxine aqueous materials |
| US7101569B2 (en) | 2001-08-14 | 2006-09-05 | Franz G Andrew | Methods of administering levothyroxine pharmaceutical compositions |
| US20030199587A1 (en) * | 2001-08-14 | 2003-10-23 | Franz G. Andrew | Levothyroxine compositions having unique Cmax properties |
| US20030203967A1 (en) * | 2001-08-14 | 2003-10-30 | Franz G. Andrew | Levothyroxine compositions having unique Tmax properties |
| US20030195253A1 (en) * | 2001-08-14 | 2003-10-16 | Franz G. Andrew | Unadsorbed levothyroxine pharmaceutical compositions, methods of making and methods of administration |
| US20030171436A1 (en) * | 2001-10-29 | 2003-09-11 | Franz G. Andrew | Levothyroxine compositions having unique triiodothyronine Tmax properties |
| US7449605B2 (en) * | 2003-11-03 | 2008-11-11 | Ilypsa, Inc. | Crosslinked amine polymers |
| US7385012B2 (en) * | 2003-11-03 | 2008-06-10 | Ilypsa, Inc. | Polyamine polymers |
| US7608674B2 (en) * | 2003-11-03 | 2009-10-27 | Ilypsa, Inc. | Pharmaceutical compositions comprising cross-linked small molecule amine polymers |
| US7767768B2 (en) * | 2003-11-03 | 2010-08-03 | Ilypsa, Inc. | Crosslinked amine polymers |
| US7459502B2 (en) * | 2003-11-03 | 2008-12-02 | Ilypsa, Inc. | Pharmaceutical compositions comprising crosslinked polyamine polymers |
| US7335795B2 (en) | 2004-03-22 | 2008-02-26 | Ilypsa, Inc. | Crosslinked amine polymers |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3516794A (en) * | 1964-12-14 | 1970-06-23 | Squibb & Sons Inc | Apparatus and method for determining thyroid function |
| US3721528A (en) * | 1970-06-04 | 1973-03-20 | L Mead | Method and apparatus for measuring the amount of a component in a biological fluid |
| US3702821A (en) * | 1970-12-14 | 1972-11-14 | Bio Chem Procedures Inc | Serum thyroxine anion exchange resin |
| US3743482A (en) * | 1970-12-30 | 1973-07-03 | Nuclear Med Lab | Method and apparatus for determining thyroid function |
| US3823001A (en) * | 1971-05-06 | 1974-07-09 | Bio Rad Laboratories | Determination of thyroid hormone uptake |
| US3784489A (en) * | 1972-03-06 | 1974-01-08 | M Dales | Anion exchange resins from alkylated condensation polymers of polyethyleneimine and dihaloalkanes |
| US3929981A (en) * | 1974-02-27 | 1975-12-30 | Squibb & Sons Inc | Method for determining thyroid function |
-
1976
- 1976-05-12 US US05/685,595 patent/US4015939A/en not_active Expired - Lifetime
- 1976-12-23 GB GB53800/76A patent/GB1557267A/en not_active Expired
-
1977
- 1977-01-14 DE DE19772701462 patent/DE2701462A1/de not_active Withdrawn
- 1977-01-17 CA CA269,836A patent/CA1059411A/en not_active Expired
- 1977-05-12 JP JP5481977A patent/JPS52138996A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| US4015939A (en) | 1977-04-05 |
| JPS6122781B2 (https=) | 1986-06-03 |
| GB1557267A (en) | 1979-12-05 |
| DE2701462A1 (de) | 1977-12-01 |
| JPS52138996A (en) | 1977-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA1059411A (en) | Competitive binding thyroid assay with improved bound-free separation step | |
| US4115537A (en) | Resin tablet and use thereof in diagnostic tests | |
| US4108974A (en) | Radioimmunoassay for thyroid hormone | |
| EP0015687A1 (en) | Measurements of free ligands | |
| CA1108986A (en) | Specific binding assay employing polyvinyl alcohol as separating agent | |
| CA1050425A (en) | Radioimmunoassay methods for the determination of l-triiodothyronine and thyroxine | |
| Banerjee et al. | Colcemid and colchicine binding to tubulin. Similarity and dissimilarity | |
| US3659104A (en) | Method of measuring serum thyroxine | |
| US4211763A (en) | Anion exchange resin in the determination of thyroid function | |
| US4135880A (en) | Folate assay with ion exchange resin bound-free separation | |
| CA1084394A (en) | Extraction-free cortisol assay | |
| EP0341439A1 (en) | Method for increasing specificity in competitive immunoassays | |
| US4158703A (en) | T3 uptake test employing covalently bound bovine serum albumin | |
| US4225784A (en) | Covalently bound biological substances to plastic materials and use in radioassay | |
| US4081246A (en) | Solid phase column immunoassay procedure employing novel immunochemical composites | |
| US5589395A (en) | Method for stabilizing annexins | |
| US4062936A (en) | Carrier for immunochemical measurement | |
| US4399229A (en) | Rapid radioimmunoassay product and method of making and using same | |
| Thorén | The influence of iodide and iodized compounds on the PBI and the 131I tracer test with special reference to various biologic states of the thyroid | |
| CA1039185A (en) | Hypothyroid serum control | |
| Massaglia et al. | Fractionation of antibodies to testosterone | |
| US4066410A (en) | Thyroid hormone assay | |
| US3709985A (en) | Method for determining total blood serum iron-binding capacity | |
| US3929981A (en) | Method for determining thyroid function | |
| TSUCHIHASHI et al. | Characterization of 3H-dihydroalprenolol binding to β-adrenergic receptors of rat brain: two binding sites of racemic propranolol in displacement experiments |